Clinical Trial Update: Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Cipros 10 Association for isolated hypertriglyceridemia and dyslipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertriglyceridemia

Drugs mentioned

• Cipros 10 Association

Snippet

Sponsor: EMS | Conditions: Hypertriglyceridemia, Dyslipidemia | Phase 3 | Status: COMPLETED